Literature DB >> 26090916

Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.

Andrea Barison1, Alberico Del Torto, Sara Chiappino, Giovanni Donato Aquaro, Giancarlo Todiere, Giuseppe Vergaro, Claudio Passino, Massimo Lombardi, Michele Emdin, Pier Giorgio Masci.   

Abstract

AIMS: In nonischaemic dilated cardiomyopathy (NICM), replacement myocardial fibrosis as detected by late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) is associated with poor prognosis. We investigated the as-yet unexplored prognostic significance of interstitial fibrosis in NICM, using T1-mapping CMR.
METHODS: Eighty-nine NICM patients (63 men, age 59 ± 14 years) with left ventricular systolic dysfunction (ejection fraction 41 ± 13%) underwent comprehensive clinical and CMR evaluation, with extracellular volume fraction (ECV) estimation from pre and postcontrast T1 mapping. Fifteen healthy individuals (11 men, mean age 52 ± 11 years) were used as controls. The end-point was a composite of cardiovascular death, hospitalization for heart failure and appropriate defibrillator intervention.
RESULTS: Myocardial ECV was higher in NICM patients (0.31 ± 0.05) than controls (0.25 ± 0.04, P < 0.01). In NICM patients, myocardial ECV correlated with left ventricular ejection fraction (R = 0.13), LGE extent (R = 0.17), Doppler E/E' (R = 0.17) and ventricular tachycardias (R = 0.21) at 24-h ECG monitoring (P < 0.05 for all). During a median follow-up of 24 months (interquartile range 12-42 months), 12 events occurred and higher myocardium ECV was independently associated with the occurrence of the composite end-point (P < 0.01).
CONCLUSION: In NICM patients, myocardial ECV was increased compared with normal individuals, likely reflecting extracellular matrix remodelling and collagen deposition, and resulted an independent prognostic predictor beyond all other conventional clinical, electrocardiographic and echocardiographic parameters.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26090916     DOI: 10.2459/JCM.0000000000000275

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  21 in total

1.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

2.  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia.

Authors:  Omar Niss; Robert Fleck; Fowe Makue; Tarek Alsaied; Payal Desai; Jeffrey A Towbin; Punam Malik; Michael D Taylor; Charles T Quinn
Journal:  Blood       Date:  2017-05-15       Impact factor: 22.113

Review 3.  Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Authors:  Andrea Barison; Chrysanthos Grigoratos; Giancarlo Todiere; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 4.  Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging.

Authors:  Ilona A Dekkers; Hildo J Lamb
Journal:  Br J Radiol       Date:  2018-07-23       Impact factor: 3.039

5.  Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.

Authors:  Keisuke Inui; Kuniya Asai; Masaki Tachi; Aya Yoshinaga; Yuki Izumi; Yoshiaki Kubota; Koji Murai; Yayoi Tetsuou Tsukada; Yasuo Amano; Shinichiro Kumita; Wataru Shimizu
Journal:  Heart Vessels       Date:  2018-03-20       Impact factor: 2.037

6.  Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.

Authors:  Jong-Chan Youn; Yoo Jin Hong; Hye-Jeong Lee; Kyunghwa Han; Chi Young Shim; Geu-Ru Hong; Young Joo Suh; Jin Hur; Young Jin Kim; Byoung Wook Choi; Seok-Min Kang
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

7.  The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure.

Authors:  Robert D Adam; James Shambrook; Andrew S Flett
Journal:  Card Fail Rev       Date:  2017-11

8.  Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.

Authors:  Fuhai Li; Mengying Xu; Yuyuan Fan; Yanyan Wang; Yu Song; Xiaotong Cui; Mingqiang Fu; Baozheng Qi; Xueting Han; Jingmin Zhou; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-01       Impact factor: 2.357

9.  Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Baiyan Zhuang; Arlene Sirajuddin; Shuli Wang; Andrew Arai; Shihua Zhao; Minjie Lu
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 10.  CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.

Authors:  Laura Keil; Céleste Chevalier; Paulus Kirchhof; Stefan Blankenberg; Gunnar Lund; Kai Müllerleile; Christina Magnussen
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.